The genomic landscape of blood groups in Indigenous Australians in remote communities. Issue 5 (11th April 2022)

• Record Type: Journal Article
• Authors: Jadhao, Sudhir; Hoy, Wendy; Lee, Simon; Patel, Hardip R.; McMorran, Brendan J.; Flower, Robert L.; Nagaraj, Shivashankar H.
• Is Part Of: Transfusion. Volume 62:Issue 5(2022)
• Page Start: 1110
• Page End: 1120
• Publication Date: 2022-04-11
• Subjects: alloimmunisation -- blood group system -- next‐generation sequencing (NGS) -- novel antigen -- rare antigen -- red blood cells -- single nucleotide variants (SNV) -- transfusion -- weak antigen; Hematology -- Periodicals; Blood -- Transfusion -- Periodicals; Blood Group Antigens -- Periodicals; Blood Preservation -- Periodicals; Blood Transfusion -- Periodicals; 615
• DOI: 10.1111/trf.16873
• Languages: English
• ISSNs: 0041-1132

Abstract

Abstract: Background: Red blood cell (RBC) membrane‐associated blood group systems are clinically significant. Alloimmunisation is a persistent risk associated with blood transfusion owing to the antigen polymorphisms among these RBC‐associated blood groups. Next‐generation sequencing (NGS) offers an opportunity to characterize the blood group variant profile of a given individual. Australia comprises a large multiethnic population where most blood donors are Caucasian and blood group variants remain poorly studied among Indigenous Australians. In this study, we focused on the Tiwi Islanders, who have lived in relative isolation for thousands of years. Methods and materials: We predicted the blood group phenotype profiles in the Tiwi (457) and 1000 Genomes Phase 3 (1KGP3‐2504) cohort individuals using RBCeq (https://www.rbceq.org/ ). The predicted phenotype prevalence was compared with the previous literature report. Results: We report, for the first time, comprehensive blood group profiles corresponding to the 35 known blood group systems among the Indigenous Tiwi islander population and identify possible novel antigen variants therein. Our results demonstrate that the genetic makeup of the Tiwi participants is distinct from that of other populations, with a low prevalence of LU (Au[a−b+]) and ABO (A2) and D+C+c+E+e− phenotype, an absence of Diego blood group variants, and a unique RHD (DIII type4) variant. Conclusion: Our results may contribute to the development of a database of predicted phenotype donors among the Tiwi population and aid in improving transfusion safety for the ~2800 Tiwi people and the ~800, 000 other Indigenous Australians throughout the nation.